Bart Remmerie
Impact in
- Psychiatry and Mental health top 1%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Epilepsy research and treatment
- Toxicology top 2%
Papers in
-
- Schizophrenia research and treatment 28
- Bipolar Disorder and Treatment 10
- Epilepsy research and treatment 7
-
- Pharmaceutical studies and practices 13
- Pharmacological Effects and Toxicity Studies 5
- Co-authors
- Mariëlle Eerdekens (10 shared papers)David Hough (12 shared papers)Srihari Gopal (11 shared papers)Erik Mannaert (6 shared papers)Cristiana Gassmann-Mayer (3 shared papers)Rosanne Lane (4 shared papers)Joris Berwaerts (8 shared papers)Isaac Nuamah (6 shared papers)
- Journals
- The Journal of Clinical Pharmacology (4 papers)Clinical Therapeutics (3 papers)Schizophrenia Research (3 papers)The International Journal of Neuropsychopharmacology (2 papers)CPT Pharmacometrics & Systems Pharmacology (2 papers)
- Partner nations
- United StatesBelgiumNetherlands
In The Last Decade
Bart Remmerie
44 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 87
- Psychiatry and Mental health 1.2k
- Toxicology 107
- Biological Psychiatry 74
- Philosophy 219
- Pediatrics, Perinatology and Child Health 330
Countries citing papers authored by Bart Remmerie
This map shows the geographic impact of Bart Remmerie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Remmerie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Remmerie more than expected).
Fields of papers citing papers by Bart Remmerie
This network shows the impact of papers produced by Bart Remmerie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Remmerie. The network helps show where Bart Remmerie may publish in the future.
Co-authors
The 25 scholars most cited alongside Bart Remmerie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 159 | |
| 2 | 2010 | 143 | |
| 3 | 2004 | 133 | |
| 4 | 2008 | 133 | |
| 5 | 2010 | 133 | |
| 6 | 2011 | 101 | |
| 7 | 2005 | 88 | |
| 8 | 2002 | 78 | |
| 9 | 2015 | 65 | |
| 10 | 2008 | 56 | |
| 11 | 2018 | 55 | |
| 12 | 2012 | 51 | |
| 13 | 2000 | 50 | |
| 14 | 2010 | 49 | |
| 15 | 2009 | 41 | |
| 16 | 2014 | 39 | |
| 17 | 2003 | 37 | |
| 18 | 2007 | 35 | |
| 19 | 2009 | 32 | |
| 20 | 2020 | 31 |
About Bart Remmerie
Bart Remmerie is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health, Neurology, Epidemiology and Infectious Diseases, having authored 46 papers that have together received 1.7k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (28 papers), Pharmaceutical studies and practices (13 papers), Bipolar Disorder and Treatment (10 papers), Epilepsy research and treatment (7 papers), Pharmacological Effects and Toxicity Studies (5 papers), Botulinum Toxin and Related Neurological Disorders (5 papers), Respiratory viral infections research (4 papers) and Pharmacovigilance and Adverse Drug Reactions (3 papers). The work is most often cited by research in Psychiatry and Mental health (1.2k citations), Toxicology (107 citations), Biological Psychiatry (74 citations), Philosophy (219 citations) and Pediatrics, Perinatology and Child Health (330 citations). Bart Remmerie has collaborated with scholars based in United States, Belgium and Netherlands. Frequent co-authors include Mariëlle Eerdekens, David Hough, Srihari Gopal, Erik Mannaert, Cristiana Gassmann-Mayer, Rosanne Lane, Joris Berwaerts, Isaac Nuamah, Marc De Meulder and Ilse Van Hove. Their work appears in journals such as The Journal of Clinical Pharmacology, Clinical Therapeutics, Schizophrenia Research, The International Journal of Neuropsychopharmacology and CPT Pharmacometrics & Systems Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.